)
Visual
test
Allurion Technologies
Allurion Technologies (ALUR) investor relations material
Allurion Technologies Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration Filing summary9 Jan, 2026
Company overview and business model
Focuses on a weight loss platform featuring a swallowable, procedureless intragastric balloon (Allurion Smart Capsule) and AI-powered remote patient monitoring tools, behavior change programs, and telehealth services delivered via the Allurion Virtual Care Suite.
Products are sold internationally, with a premarket application submitted to the FDA for U.S. approval.
The platform is designed for metabolically healthy weight loss, aiming for fat reduction while maintaining muscle mass, and is compatible with other weight loss therapies.
Financial performance and metrics
As of January 5, 2026, there were 12,279,181 shares of common stock outstanding and no preferred stock outstanding.
The last quoted sale price for common stock on January 8, 2026, was $1.70 per share on the NYSE.
Use of proceeds and capital allocation
May receive up to $5.0 million in cash proceeds from the exercise of November 2025 Private Placement Warrants; proceeds will be used for working capital and general corporate purposes.
Pending use, proceeds may be invested in investment-grade, interest-bearing securities or held as cash.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Allurion Technologies
- Innovative gastric balloon and digital platform target obesity with strong growth and U.S. expansion ahead.ALUR
Small-Cap Growth Virtual Investor Conference3 Feb 2026 - Innovative weight loss balloon and digital platform fuel growth, with U.K. reimbursement and U.S. expansion.ALURJefferies 2024 Global Healthcare Conference1 Feb 2026
- Q2 revenue up 25% sequentially, but France suspension and NYSE risks weigh on outlook.ALURQ2 20241 Feb 2026
- Q3 revenue dropped 71% as AI sales soared and restructuring targets 2025 profitability.ALURQ3 202414 Jan 2026
- 2024 revenue reached $32.1M, with cost cuts and growth in GLP-1 combination therapy.ALURQ4 202426 Dec 2025
- Allurion pivots to B2B2C, cuts costs, and eyes FDA approval for US launch in 2026.ALURTD Cowen 45th Annual Healthcare Conference26 Dec 2025
- Shelf registration for up to $100M supports global obesity platform expansion amid high risks.ALURRegistration Filing16 Dec 2025
- Shelf registration allows up to $100M in securities with strong governance and legal compliance.ALURRegistration Filing16 Dec 2025
- Registering 6.1M+ shares for resale, with up to $19.7M in potential warrant proceeds.ALURRegistration Filing16 Dec 2025
Next Allurion Technologies earnings date
Q4 20253 Apr, 2026
Allurion Technologies
Next Allurion Technologies earnings date
Q4 20253 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage